Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-19T13:20:19.516Z Has data issue: false hasContentIssue false

Impact of Ventilator-Associated Pneumonia on Resource Utilization and Patient Outcome

Published online by Cambridge University Press:  02 January 2015

Stéphane Hugonnet
Affiliation:
Infection Control Program, University of Geneva Hospitals, Geneva, Switzerland
Philippe Eggimann
Affiliation:
Medical Intensive Care Unit, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
François Borst
Affiliation:
Medico-economic Unit, Department of Radiology, University of Geneva Hospitals, Geneva, Switzerland
Patrice Maricot
Affiliation:
Medico-economic Unit, Department of Radiology, University of Geneva Hospitals, Geneva, Switzerland
Didier Pittet*
Affiliation:
Infection Control Program, University of Geneva Hospitals, Geneva, Switzerland
*
Infection Control Program, Department of Internal Medicine, University of Geneva Hospitals, 1211 Geneva 14, Switzerland

Abstract

Objective:

To assess the effect of ventilator-associated pneumonia on resource utilization, morbidity, and mortality.

Design:

Retrospective matched cohort study based on prospectively collected data.

Setting:

Medical intensive care unit of a university teaching hospital.

Patients:

Case-patients were all patients receiving mechanical ventilation for 48 hours or more who experienced an episode of ventilator-associated pneumonia. Control-patients were matched for number of discharge diagnoses, duration of mechanical support before the onset of pneumonia among case-patients, age, admission diagnosis, gender, and study period.

Results:

One hundred six cases of ventilator-associated pneumonia were identified in 452 patients receiving mechanical ventilation. The matching procedure selected 97 pairs. Length of stay in the intensive care unit and duration of mechanical ventilation were greater among case-patients by a mean of 7.2 days (P< .001) and 5.1 days (P< .001), respectively. Median costs were $24,727 (interquartile range, $18,348 to $39,703) among case-patients and $17,438 (interquartile range, $12,261 to $24,226) among control-patients (P< .001). The attributable mortality rate was 7.3% (P = .26). The attributable extra hospital stay was 10 days with an extra cost of $15,986 per episode of pneumonia.

Conclusion:

Ventilator-associated pneumonia negatively affects patient outcome and represents a significant burden on intensive care unit and hospital resources.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kohn, L, Corrigan, J, Donaldson, M. To Err Is Human: Building a Safer Health System. Washington, DC: Institute of Medicine; 1999.Google Scholar
2.Public health focus: surveillance, prevention, and control of nosocomial infections. MMWR 1992;41:783787.Google Scholar
3.Vincent, JL, Bihari, DJ, Suter, PM, et al.The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995;274:639644.CrossRefGoogle ScholarPubMed
4.Cook, D. Ventilator associated pneumonia: perspectives on the burden of illness. Intensive Care Med 2000;26(suppl 1):S31S37.Google Scholar
5.Centers for Disease Control and Prevention NNIS System. National Nosocomial Infections Surveillance (NNIS) System reports: data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000;28:429448.CrossRefGoogle Scholar
6.Cook, DJ, Walter, SD, Cook, RJ, et al.Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433440.CrossRefGoogle ScholarPubMed
7.Finkelstein, R, Rabino, G, Kassis, I, Mahamid, I. Device-associated, device-day infection rates in an Israeli adult general intensive care unit. J Hosp Infect 2000;44:200205.CrossRefGoogle Scholar
8.Wallace, WC, Cinat, M, Gornick, WB, Lekawa, ME, Wilson, SE. Nosocomial infections in the surgical intensive care unit: a difference between trauma and surgical patients. Am Surg 1999;65:987990.Google Scholar
9.Richards, MJ, Edwards, JR, Culver, DH, Gaynes, RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000;21:510515.Google Scholar
10.Esteban, A, Anzueto, A, Frutos, F, et al.Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002;287:345355.CrossRefGoogle ScholarPubMed
11.Fagon, JY, Chastre, J, Domart, Y, et al.Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Sespir Dis 1989;139:877884.Google Scholar
12.Fagon, JY, Chastre, J, Vuagnat, A, Trouillet, JL, Novara, A, Gibert, C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996;275:866869.Google Scholar
13.Heyland, DK, Cook, DJ, Griffith, L, Keenan, SP, Brun-Buisson, C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient: the Canadian Critical Trials Group. Am J Respir Crit Care Med 1999;159:12491256.Google Scholar
14.Kollef, MH. Ventilator-associated pneumonia. JAMA 1993;270:19651970.CrossRefGoogle ScholarPubMed
15.Rello, J, Quintana, E, Ausina, V, et al.Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991;100:439444.Google Scholar
16.Fagon, JY, Chastre, J, Hance, AJ, Montravers, P, Novara, A, Gibert, C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281288.Google Scholar
17.Ibrahim, EH, Ward, S, Sherman, G, Kollef, MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000;117:14341442.Google Scholar
18.Rello, J, Ollendorf, DA, Oster, G, et al.Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:21152121.Google Scholar
19.Craven, DE, Kunches, LM, Lichtenberg, DA. Nosocomial infection and fatality in medical surgical intensive care unit patients. Arch Intern Med 1988;148:11611168.Google Scholar
20.Ibrahim, EH, Tracy, L, Hill, C, Fraser, VJ, Kollef, MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 2001;120:555561.CrossRefGoogle Scholar
21.Papazian, L, Bregeon, F, Thirion, X, et al.Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996;154:9197.CrossRefGoogle ScholarPubMed
22.Eggimann, P, Harbarth, S, Constantin, MN, Touveneau, S, Chevrolet, JC, Pittet, D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000;355:18641868.CrossRefGoogle ScholarPubMed
23.Hugonnet, S, Eggimann, P, Sax, H, Touveneau, S, Chevrolet, J-C, Pittet, D. ICU-acquired infections: is post-discharge surveillance useful? Crit Care Med 2002;30:26362638.Google Scholar
24.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128140.CrossRefGoogle ScholarPubMed
25.Centers for Disease Control. CDC definitions for nosocomial infections, 1988. Am Rev Respir Dis 1989;139:10581059.Google Scholar
26.Pittet, D, Harbarth, S, Ruef, C, et al.Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol 1999;20:3742.Google Scholar
27.Meduri, GU, Johanson, WG JrInternational consensus conference: clinical investigation of ventilator-associated pneumonia. Introduction. Chest 1992;102(suppl 1):S551S552.Google Scholar
28.Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996;153:17111725.Google Scholar
29.Martin, MA, Pfaller, MA, Wenzel, RP. Coagulase-negative staphylococcal bacteremia: mortality and hospital stay. Ann Intern Med 1989;110:916.CrossRefGoogle ScholarPubMed
30.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:15981601.Google Scholar
31.Haley, RW. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. Am J Med 1991;91(suppl 3B):S32S38.Google Scholar
32.Haley, RW, Schaberg, DR, Von Allmen, SD, McGowan, JE JrEstimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis 1980;141:248257.Google Scholar
33.National Nosocomial Infections Surveillance (NNIS) System. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001;29:404421.CrossRefGoogle Scholar
34.Baker, AM, Meredith, JW, Haponik, EF. Pneumonia in intubated trauma patients: microbiology and outcomes. Am J Respir Crit Care Med 1996;153:343349.CrossRefGoogle ScholarPubMed
35.Bercault, N, Boulain, T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001;29:23032309.CrossRefGoogle Scholar
36.Kappstein, I, Schulgen, G, Beyer, U, Geiger, K, Schumacher, M, Daschner, FD. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11:504508.Google Scholar
37.Craig, CP, Connelly, S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control 1984;12:233238.Google Scholar
38.Cunnion, KM, Weber, DJ, Broadhead, WE, Hanson, LC, Pieper, CF, Rutala, WA. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med 1996;153:158162.CrossRefGoogle ScholarPubMed
39.Devos, N, Pinsard, M, Rigaud, JP, Berthelot, G, Canonne, M. Morbidité et mortalité des pneumopathies acquises sous ventilation mécanique (PAVM). Réanimation 2001;10(suppl 1):S158.Google Scholar
40.Rello, J, Jubert, P, Valles, J, Artigas, A, Rue, M, Niederman, MS. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996;23:973978.Google Scholar
41.Eggimann, P, Pittet, D. Infection control in the ICU. Chest 2001;120:20592093.CrossRefGoogle ScholarPubMed
42.Kollef, MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999;340:627634.Google Scholar
43.Finkler, SA. The distinction between cost and charges. Ann Intern Med 1982;96:102109.Google Scholar
44.Stone, PW, Larson, E, Kawar, LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control 2002;30:145152.Google Scholar
45.Graves, N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004;10:561566.Google Scholar
46.Russell, LB, Gold, MR, Siegel, JE, Daniels, N, Weinstein, MC. The role of cost-effectiveness analysis in health and medicine: panel on cost-effectiveness in health and medicine. JAMA 1996;276:11721177.Google Scholar
47.Weinstein, MC, Siegel, JE, Gold, MR, Kamlet, MS, Russell, LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:12531258.CrossRefGoogle ScholarPubMed
48.Borst, F, Appel, R, Baud, R, et al.Happy Birthday DIOGENE: a hospital information system born 20 years ago. Int J Med Inf 1999;54:157167.Google Scholar
49.Borst, F, Maricot, P. An intranet visualization of costs per AP-DRGs in a Swiss teaching hospital. In: Hofdijk, J, Bouwes-Westrup, H, de Langen, ZJ, eds. Proceedings of the 16th PCS/E International Working Conference, 24 September 2000, Groningen, The Netherlands. 2000:35.Google Scholar
50.Warren, DK, Shukla, SJ, Olsen, MA, et al.Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:13121317.Google Scholar
51.Fagon, J-Y, Chastre, J, Wolff, M, et al.Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 2000;132:621630.Google Scholar
52.Pittet, D, Bonten, MJ. Towards invasive diagnostic techniques as standard management of ventilator-associated pneumonia. Lancet 2000;356:874.CrossRefGoogle ScholarPubMed
53.Minei, JP, Hawkins, K, Moody, B, et al.Alternative case definitions of ventilator-associated pneumonia identify different patients in a surgical intensive care unit. Shock 2000;14:331336.Google Scholar
54.Timsit, JF, Chevret, S, Valcke, J, et al.Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Respir Crit Care Med 1996;154:116123.Google Scholar